(Q39225346)
Statements
1 reference
Post marketing surveillance of sublingual buprenorphine naloxone combination tablets (English)
1 reference
Rajat Ray
1 reference
Meera Vaswani
1 reference
Koushik Sinha Deb
1 reference
Hem Sethi
1 reference
Anita Chopra
1 reference
Nand Kishore
1 reference
Rakesh Goyal
1 reference
1 October 2012
1 reference
1 reference
56
1 reference
4
1 reference
359-366
1 reference
Identifiers
1 reference